Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07431931 · ClinicalTrials.gov registry record · NA
Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria
A NA study, sponsored by Geisinger Clinic.
- Not yet
- Registry status
- NA
- Development phase
- 1,200
- Enrollment target
NCT07431931: Clinical Trial NA study, sponsored by Geisinger Clinic.
NCT07431931 is a NA study that has not yet begun recruiting, run by Geisinger Clinic. The registered enrollment target is 1,200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07431931, a NA study, has not yet begun recruiting, sponsored by Geisinger Clinic.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate prospectively the impact of an electronic health record (EHR) alert on primary care providers' (PCP) referral to Nephrology of Geisinger patients with high risk signs (blood and protein in the urine) of glomerulonephritis. This will help quantify the relative effectiveness of EHR alerts on PCPs' referral patterns.
Primary Outcome
Proportion of adult patients with high-risk features for glomerulonephritis with a nephrology referral order
Interventions
- OTHER Electronic Health Record alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2026-11 |
| Est. Completion | 2027-12 |
| Phase | NA |
What is known before NCT07431931 opens enrollment
NCT07431931 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 1 intervention - of which Electronic Health Record alert is the first listed.
NCT07431931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07431931 about?
NCT07431931 is a clinical study titled "Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria". The purpose of the study is to evaluate prospectively the impact of an electronic health record (EHR) alert on primary care providers' (PCP) referral to Nephrology of Geisinger patients with high risk signs (blood and protein in the urine) of glomerulonephritis. This will help quantify the relative ...
What is the current status of trial NCT07431931?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2026-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07431931?
The interventions under investigation include: Electronic Health Record alert (OTHER).
Who is sponsoring clinical trial NCT07431931?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07431931's enrollment target sits among peer trials
1,200 83rd of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia